Better Buy: Biogen Inc. vs. Gilead Sciences
Historically, Biogen (NASDAQ: BIIB) has definitely been a better stock than Gilead Sciences (NASDAQ: GILD). Whether you look at the last three, five, 10, 25 years, or even so far in 2017, Biogen has outperformed Gilead.
But for investors, the future matters a whole lot more than the past. Which of these two big biotech stocks is the better pick going forward? Here's how Biogen and Gilead Sciences compare.
Image source: Getty Images.
Source: Fool.com
Gilead Sciences Inc Stock
€61.99
0.000%
With 11 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 84 € shows a positive potential of 35.51% compared to the current price of 61.99 € for Gilead Sciences Inc.
